Fluticasone propionate and salmeterol
Wixela Inhub is a prescription inhaler combining fluticasone propionate (a corticosteroid to reduce inflammation) and salmeterol (a long-acting bronchodilator to open airways). It's used to treat asthma and chronic obstructive pulmonary disease (COPD) in adults and some children. Inhale as directed by your doctor. This information was generated using AI and is provided for informational and research purposes only.
Complete Metadata
| @type | dcat:Dataset |
|---|---|
| accessLevel | public |
| accrualPeriodicity | R/P1Y |
| bureauCode |
[
"009:10"
]
|
| contactPoint |
{
"fn": "Division of Drug Information",
"@type": "vcard:Contact",
"hasEmail": "mailto:druginfo@fda.hhs.gov"
}
|
| description | Wixela Inhub is a prescription inhaler combining fluticasone propionate (a corticosteroid to reduce inflammation) and salmeterol (a long-acting bronchodilator to open airways). It's used to treat asthma and chronic obstructive pulmonary disease (COPD) in adults and some children. Inhale as directed by your doctor. This information was generated using AI and is provided for informational and research purposes only. |
| distribution |
[
{
"@type": "dcat:Distribution",
"title": "Fluticasone propionate and salmeterol",
"mediaType": "text/html",
"description": "
Access the FDA dataset for Fluticasone propionate and salmeterol — ANDA 213948 submitted by Mylan Institutional LLC
",
"downloadURL": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=213948"
}
]
|
| identifier | ANDA213948 |
| issued | 2016-09-16 |
| keyword |
[
"drug",
"drug-information",
"drug-manufacturers",
"pharmaceuticals",
"prescription-drugs"
]
|
| landingPage | https://www.fda.gov/drugs |
| license | https://open.fda.gov/license |
| modified | 2025-03-17 |
| programCode |
[
"009:002"
]
|
| publisher |
{
"name": "U.S. Food and Drug Administration",
"@type": "org:Organization"
}
|
| theme |
[
"FDA"
]
|
| title | Fluticasone propionate and salmeterol |
